Article Text

PDF
Introducing the new BTS Guideline: Management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
  1. Charles S Haworth1,
  2. R Andres Floto1,2
  1. 1 Cambridge Centre for Lung Infection, Papworth Hospital, Cambridge, UK
  2. 2 Department of Medicine, University of Cambridge, Cambridge, UK
  1. Correspondence to Dr Charles S Haworth, Cambridge Centre for Lung Infection, Papworth Hospital, Cambridge CB23 3RE, UK; charles.haworth{at}nhs.net

Abstract

The new BTS Guidelines for the management of non-tuberculous mycobacterial pulmonary disease combine the best available evidence with expert consensus to generate a set of pragmatic Guidelines, published as a supplement to this issue of Thorax, to assist in the management of these challenging infections.

  • Respiratory Infection
  • Opportunist Lung Infections

Statistics from Altmetric.com

Footnotes

  • Competing interests RAF has received funding from Insmed. CSH has received funding from Aradigm, Chiesi, Gilead, Insmed, Raptor, Teva, Vertex, Zambon.

  • Provenance and peer review Commissioned; internally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.